|About the author:
||Lomikovska M.P., Hayduchok I.G., Potomkina H.O., Zubchenko S.O., Kril I.Y., Ishcheykin K.Y., Chopyak V.V.
|Type of article
||The work presents the study findings on the TLR9 expression in immune competent cells in reactive arthritis patients with chronic Epstein-Barr virus infection, and considers the possibility of the reactive arthritis transformation into rheumatoid arthritis. It was established that expression of TLR9+CD123+ on monocytes was reliably higher in the blood of reactive arthritis patients as compared to healthy individuals, while in patients in active phase of EBV-infection the expression of this receptor was reliably higher as compared to similar indices of patients at the latent phase. At that, the number of TLR9+CD123+-monocytes in patients with reactive and rheumatoid arthritis was not reliably different. The number of TLR9+CD123+-lymphocytes as compared to indices of healthy individuals was reliably higher in patients with rheumatoid arthritis at both phases of chronic EBV-infection, while in patients with reactive arthritis it was only characteristic at the active phase of the infection. Expression of this receptor on lymphocytes turned out to be reliably higher in patients with rheumatoid arthritis as compared to patients with reactive arthritis, particularly at the active phase of chronic EBV infection.
||reactive arthritis , rheumatoid arthritis, chronic Epstein-Barr Virus Infection, TLR9
- Boyko YY, Chernyshov VP. Tsytokinovi markery ta prohnostychni faktory nespryyatlyvoho perebihu yuvenilʹnoho idiopatychnoho artrytu. Ukrayinskyy revmatolohichnyy zhurnal. 2012; 49(3):16-21. [in Ukrainian]
- Volkov MY. Rol Toll-podobnykh retseptorov i ikh endogennykh ligandov v patogeneze revmatoidnogo artrita (obzor literatury). Nauchno-prakticheskaya revmatologiya. 2016; 1(54): 78-85. [in Russian]
- Zubchenko SO Lymphogram’s peculiarities of Patients with Chronic Epstein-Barr Virus Infection at the Stage of the Replicative of the Virus and Autoimmune Syndrome Symptoms. Nauka i Studia. 2014; 123(13): 62-69. [in Ukrainian]
- Chopyak VV, Potemkina HA, Zubchenko SO. Monitoring effektivnosti ispolzovaniya groprinozina na osnovanii analiza ekspresii TLR9 na immunokompetnykh kletkakh pri lechenii khronicheskoy Epshteyna-Barr virusnoy infektsii v stadii replikativnoy aktivnosti. Nauchno-teoreticheskiy i prakticheskiy zhurnal «Oraldyn Gylym Zharshysy». 2014; 86(7): 69-77. [in Ukrainian]
- Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2016; 50(1): 1-17.
- Davis ML, LeVan TD, Yu F, Sayles H, Sokolove J, et al. Associations of toll-like receptor (TLR)-4 single nucleotide polymorphisms and rheumatoid arthritis disease progression: An observational cohort study. Int Immunopharmacol. 2015; 24: 346–352.
- Duffy L, O’Reilly SC. Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments. Immunotargets Ther. 2016; 5: 1–7.
- Fiola S, Gosselin D, Takada K, Gosselin J. TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J. Immunol. 2010; 185: 3620–3631.
- Goh FG, Midwood KS. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford). 2012; 1(51): 7-23.
- Ivashkiv LB. PTPN22 in autoimmunity: different cell and different way. Immunity. 2013; 39(1): 91–93.
- Lacerte P, Brunet A, Egarnes B, Duchêne B, Brown JP, Gosselin J. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Res Ther. 2016; 18: 10.
- McGettrick, AF, O’Neill, LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr. Opin. Immunol. 2010; 1(22): 20-27.
- Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011; 2: 1. doi: 10.1186/2042-4280-2-1
- Schmitt SK. Reactive Arthritis. Infectious Diseases Clinics. 2017; 31(2): 265-277.
- Vogelpoel LT, Hansen IS, Rispens T, Muller FJ, van Capel TM, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014; 5: 5444.
|Publication of the article
||«World of Medicine and Biology» №1(71), 2020 year, 083-088 pages, index UDK 616.988.55:576.858.1]-078.73